GI & Endoscopy

Colorectal cancer is the second-leading cause of cancer death in the U.S., with more than 150,000 patients diagnosed and treated annually. 

The GI space saw numerous developments and industry moves in September. 

Patients taking GLP-1 receptor agonists have a lower risk of food retention when an esophagogastroduodenoscopy is combined with a colonoscopy, according to an Oct. 1 MedPage Today report.

Blue Cross Blue Shield of Massachusetts is encouraging its members to review options for colorectal cancer screenings amid a rise in cases, according to an Oct. 1 news release from the insurer. 

GI Alliance — the largest GI practice network in the country — will introduce Medtronic's GI Genius to its over 400 locations nationwide. 

Over the last 20 years, incidences of upper gastrointestinal cancer have increased faster in young women than young men, according to a Sept. 30 report from Endocrinology Advisor. 

Gastroenterology has seen a number of industry-changing developments in recent years, and new recommendations regarding minimum ages and the quality of colonoscopies promises even more change in the industry. 

A newly developed, teleoperated robotic endoscopy system could open up access to the procedure globally, Advanced Science News reported Sept. 30.

Researchers at the Cleveland Clinic discovered a bacterium that weakens the immune system in the gut, which could contribute to inflammatory and infectious gut diseases.

Over the last year, there have been several major changes in the field of gastroenterology, especially when it comes to colonoscopies and colorectal cancer screenings.